Allogene Therapeutics, Inc. · NASDAQ:ALLO
State Street Corp reported a 5.50% stake in Allogene Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 7, 2026
State Street Corp reported a 5.50% stake in Allogene Therapeutics, Inc., 19,025,826 shares, as a passive investor on Jun 30, 2026. Filed Aug 7, 2026 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 19,025,826
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.50% | 19,025,826 |
Source
Related
- Allogene Therapeutics, Inc.
- State Street Corp
- Allogene Therapeutics, Inc. shareholders
- Schedule 13D/A · Tpg Gp A, LLC · Sep 30, 2026
- Form 4 · Douglas Earl Martin · Aug 25, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Arie Belldegrun, M.D. · Aug 7, 2026
- Form 4 · Kazam Joshua A · Jun 23, 2026